Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin for bacterial infections in advanced cirrhosis (INFECIR2)
NCT02034279Phase 4Terminated
- Sponsor
- EASL-CLIF Consortium
- Start
- May 2014
- Primary completion
- Dec 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of albumin (human) in hepatorenal syndrome (HRS), Cirrhosis, sponsored by EASL-CLIF Consortium. Started May 2014; status: terminated.
02
Drugs
albumin (human)
03
Conditions
hepatorenal syndrome (HRS)Cirrhosis
Beyond the preview
Go deeper on NCT02034279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02034279.